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Objective: to analyze the action and coping plans related to the behavior of adhering to 
drug therapy, developed by coronary heart disease (CHD) outpatients, and to identify the 
barriers perceived to adopting this behavior.  Methods: the participants (n=59) were invited 
to formulate action plans and coping plans for the behavior of adhering to the cardio-
protective medications and the symptom-relief medications. Results: specific action plans 
for taking the medications associated with temporal markers and the sleep-wake cycle were 
shown. The most frequently reported obstacles were forgetfulness and absence of routine in 
daily living activities. The coping plans for overcoming forgetfulness were the most specific. 
Conclusion: this study’s findings support the application of implementation intentions aimed 
at optimizing adherence to drug therapy among patients with CHD.
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Planos de ação e de enfrentamento de obstáculos relacionados ao 
comportamento de adesão à terapia medicamentosa em coronariopatas
Objetivo: analisar os planos de ação e de enfrentamento de obstáculos, relacionados 
ao comportamento de adesão à terapia medicamentosa, elaborados por pacientes 
coronariopatas, em seguimento ambulatorial, e identificar as barreiras percebidas para 
adoção desse comportamento. Método: os participantes (n=59) foram convidados a 
elaborar planos de ação (action planning) e de enfrentamento de obstáculos (coping 
planning) para o comportamento de adesão aos medicamentos cardioprotetores e de alívio 
dos sintomas. Resultados: foram evidenciados planos de ação específicos para a tomada 
dos medicamentos que associaram o comportamento a marcadores temporais e ao ciclo 
vigília/sono. Os obstáculos mais frequentemente relatados foram o esquecimento e a 
ausência de rotina nas atividades de vida diária. Os planos de enfrentamento, elaborados 
para superar o esquecimento, foram os mais específicos. Conclusão: os achados deste 
estudo subsidiam a aplicação da implementação da intenção para otimizar a adesão de 
coronariopatas à terapia medicamentosa.
Descritores: Enfermagem; Uso de Medicamentos; Comportamento; Técnicas de 
Planejamento; Doença das Coronárias.
Planes de acción y de enfrentamiento de obstáculos relacionados al 
comportamiento de adhesión a la terapia medicamentosa en pacientes 
con coronariopatía
Objetivo: analizar los planes de acción y de enfrentamiento de obstáculos relacionados al 
comportamiento de adhesión a la terapia medicamentosa, elaborados por pacientes con 
coronariopatía en seguimiento de ambulatorio e identificar las barreras percibidas para 
adopción de este comportamiento. Método: los participantes (n=59) fueron invitados a 
elaborar planes de acción (action planning) y de enfrentamiento de obstáculos (coping 
planning) para el comportamiento de adhesión a los medicamentos cardio-protectores y 
de alivio de los síntomas. Resultados: fueron evidenciados planes de acción específicos 
para la tomada de los medicamentos que asociaron el comportamiento a marcadores 
temporales y al ciclo vigilia sueño. Los obstáculos más frecuentemente relatados 
fueron el olvido y la ausencia de rutina en las actividades de vida diaria. Los planes de 
enfrentamiento elaborados para superar el olvido fueron los más específicos. Conclusión: 
los hallazgos de este estudio subvencionan la aplicación de la implementación de la 
intención para optimizar la adhesión de pacientes con coronariopatía a la terapia 
medicamentosa.
Descriptores: Enfermería; Utilización de Medicamentos; Conducta; Técnicas de 
Planificación; Enfermedad Coronaria.
Introduction
In the last three decades, evidence has proven that 
treatment with beta-blockers, angiotensin converting 
enzyme inhibitors (ACE), angiotensin receptor 
antagonists (ARA II), platelet antiaggregant and lipid-
lowering drugs reduces cardiovascular events and 
mortality after acute coronary syndrome(1). Low or non- 
adherence to cardioprotective therapy after an ischemic 
event, however, has been frequently documented and 
associated with increases in cardiovascular morbidity 
and mortality(2). Interventions for improving adherence 
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to drug therapy have been developed and evaluated(3). 
Among these, those based on theoretical assumptions 
are the most remarkable, especially those based in 
social-cognitive theories, in which the intention or 
motivation for carrying out a specific behavior is the 
action’s main determinant. Positive intentions, however, 
do not always translate into the desired behavior(4). 
Although intention is a strong predictor of a behavior, 
there are reports of a gap in the Intention-Behavior 
relationship – that is, people with positive intentions 
fail to accomplish the behavior(5). Therefore, strategies 
such as the ‘implementation intentions’ have been used 
as tools for supporting motivated people to transform 
positive intentions into actions(6).
The concept of implementation intention refers 
to the shaping of action plans specifying when, where 
and how to carry out the behavior. They are defined 
as conditional plans that anticipate critical situations 
and specify how to act in such circumstances(4). Once 
the mental representation of such a situation becomes 
highly activated, the control of the behavior is delegated 
to specific situational clues which, when present, trigger 
the action, increasing the probability of the behavior to 
be accomplished(7). 
However, the planning of when, where and how to 
act does not address the habitual responses to routine 
situations which appear in response to social pressure. 
In this context, “coping planning”(8) has been used, 
which comprises a strategy focused on the transposition 
of barriers, by combining prospective plans (If/then) 
with coping strategies, that is, if barrier y should 
occur, then behavior x is undertaken to overcome it. 
It represents a mental union between anticipated risk 
situations and appropriate coping responses. Individuals 
who plan how to manage such conditions have a higher 
probability of maintaining the behavior in the existence 
of difficulties(8).
Formulating plans for implementing intentions has 
been effective in promoting health-related behaviors, 
such as physical activity(6,9) and consumption of fruit 
and vegetables(10), among others. In the literature, 
there are reports about the importance of investigating 
the quality of the action and coping plans developed in 
intervention studies(7,11). Hence, the present study is 
intended to analyze action and coping plans produced 
by patients with Coronary Heart Disease (CHD), related 
to cardioprotective and symptom-relief medication 
adherence recommended in the treatment of CHD, as 
well as identifying the perceived barriers to adopting 
this behavior. It is expected that this study’s findings 
support the application of the implementation intention 
technique for optimizing adherence to drug therapy in 
CHD.
Objectives
This study was aimed at analyzing the action 
and coping plans related to the behavior of adhering 
to cardioprotective and symptom-relief drug therapy, 
developed by outpatients with CHD. The study also 
aimed to identify the perceived barriers to adopting this 
behavior.
Methods
Sample and Procedures
This study’s data derives from a wider study(12) which 
evaluated the effectiveness of planning strategies in 
medication adherence and quality of life among patients 
with CHD. It was an experimental study, which included 
115 outpatients with CHD, aged over 18 years, with 
previous clinical manifestation of myocardial infarction 
or angina and undergoing regular follow-up for at least 
six months in one of the two participating hospitals, in 
the state of São Paulo.  The sample size was determined 
based on a pilot study (n=30), considering the change 
of the measurement of the proportion of adherence 
(difference: final minus initial) as a response variable, 
as well as the level of significance of 5% (α=0.05), 
considering a statistical power of the test of 80% (1- β). 
Therefore, a sample of 60 participants for each group 
was estimated, with the goal of detecting the same 
difference in the average percentage of proportion of 
adherence (final minus initial) between the Intervention 
Group (IG - 5.13) and Control Group (CG - 0.99) 
observed in the pilot study. Individuals were included if 
they presented effective verbal communication and had 
been continuously using at least two oral medications 
for treatment of CHD for at least the last month. 
Those who presented an ischemic event within the six 
month period prior to the data collection period were 
excluded, as were those whose drug treatment had 
been suspended or modified. The participants were 
randomized into Control (CG=56) or Intervention Group 
(IG=59). The individuals of the IG were submitted to 
Action and Coping Planning strategies and the controls 
received usual care, which consisted of regular medical 
follow-up. The present study analyses the action and 
coping plans devised by the 59 participants of the IG.
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Data Collection
The data was collected between June 2010 and 
May 2011. The participants responded to a validated 
questionnaire for gathering demographic and clinical 
data and to the Brazilian version of the Morisky Self-
Reported Measure of Medication Adherence Scale(13) for 
measuring factors related to non-adherence regarding 
cardioprotective medications, as well as to CHD 
symptom-relief drugs. The medication adherence was 
evaluated by the proportion of drug adherence and by 
the global evaluation of the adherence(14).
Data collection instruments
- Morisky Self-Reported Measure of Medication Adherence 
Scale(15): comprises four questions related to non-
adherence to medications – forgetfulness, carelessness, 
stopping taking medication due to perceiving of 
improvements and stopping taking medication due to 
perceiving of worsening of the health status. In the 
version used, the responses are structured in Likert-
type scales with four or five response options, whose 
sum generates a score varying from 4 to 18; considering 
the lower the score, the greater the favorability of 
adherence(13).
- Proportion of drug adherence(14): constructed to 
identify and quantify the medications and how they 
are used. It encompasses the variables: 1. Name, 
dosage and how the prescribed medications should 
be taken (posology); 2. Description of the way each 
medication is used, according to the used dose and 
how it should be taken, in the 24 hours prior to the 
interview; 3. Description of the use of the medications 
in the week prior to the interview and 4. Description 
of the use of the medications in the month prior to 
the interview. The proportion of adherence was then 
calculated based on the omitted doses, self-reported by 
the following calculation: [(prescribed doses – missed 
doses) X 100/doses prescribed](16). Participants were 
considered “adherents” if they obtained a percentage of 
consumption of prescribed medications which was equal 
to or greater than 80%(17). For those making use of 
more than one medication, the proportion of adherence 
was calculated by the average of the percentages of 
adherence for each medication(14). The proportion of 
adherence was analyzed as a continuous and binary 
variable – adequate (≥80% of the prescribed dose) and 
inadequate dose (<80% of the prescribed dose).
- Global evaluation of the adherence: the number and 
frequency of medications ingested was evaluated, along 
with its association with temporal markers: fasting, 
breakfast, lunch and dinner. Considering dosage and 
care, this measure was evaluated based in the following 
classification: Group I (adequate posology and adequate 
care regarding the medical prescription); Group II 
(adequate posology and inadequate care regarding the 
medical prescription), Group III (inadequate posology 
and adequate care regarding the medical prescription); 
Group IV (inadequate posology and inadequate care 
regarding the medical prescription). The use of one 
or more medications whose posology and association 
with temporal markers was not in accordance with the 
prescription was considered “inadequate care”. Patients 
classified in Group I were considered “adherents” 
and patients classified in groups II, III and IV were 
considered “non-adherents”(14).
Methodology for intervention strategies: action plans 
and coping plans
After the collection of clinical and sociodemographic 
data, health-related quality of life and adherence to the 
drug therapy, the IG participants were invited to produce 
– in partnership with the researcher – action and coping 
plans related to adherence to cardio-protective and 
symptom-relief medications. The construction of these 
plans was based on the theoretical presuppositions of 
“implementation-intentions”(6) and on a previous study 
undertaken in Brazil(9). In a specially-made spreadsheet, 
the participants formulated up to three action plans 
concerning when, where and how they intended to 
take the medications and indicated up to three possible 
obstacles to the accomplishing of this behavior. Between 
one and three strategies were developed for overcoming 
each of the obstacles listed. This limited number of 
plans was due to the difficulty which the individuals – 
being elderly and with low cognitive function – had in 
memorizing the strategies planned(18). All the plans were 
registered by the researcher by hand in the spreadsheet, 
and filed individually.
Data analysis
The characterization data was submitted to 
descriptive analysis. The plans were subjected to 
quanti-qualitative analysis, which corresponded to 
the categorization and tabulation of the plans and the 
barriers reported; with later grouping by similarity of 
themes or ideas and the determination of the frequency 
which these were reported.
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Ethical aspects
The study was approved by the local Research Ethics 
Committees (Decisions nº802/2009 and nº001-11). All 
the enrolled participants signed the Informed Consent.
Results
Characterization: Sociodemographic, Clinical and 
regarding Adherence to Drug Therapy
The sample (n=59) was mainly comprised of men 
(67.8%), with an average age of 63.4(8.9) years, 
Caucasians (72.9%), with an average of 5.5(4.0) years 
of schooling, who lived with partners (89.8%), were 
economically inactive (76.3%), and with a monthly family 
income equivalent to 3.6(3.2) minimum salaries. The 
majority (74.6%) had a previous history of myocardial 
infarction, as well as an average of 5.1(1.9) associated 
clinical conditions. Most of the individuals were using 
an average of 6.8(2.0) types of medications per day, 
average of 3.5(0.6) cardioprotective medications, and 
average of 0.9(0.7) medications for symptom-relief. The 
participants were considered adherents by the criteria 
of proportion of drug adherence and showed favorability 
for adherence according to the Morisky scale. However, 
only 19 (32.2%) persons reported using dose ≥80% and 
adopting the necessary care for the adequate use of the 
medications, which indicates non-adherence, according 
to this evaluation criteria (Table 1).
Sociodemographic Variables
Age, Average (sd*) 63.4(8.9)
Sex, % (n)
Male 67.8(40)
Color, % (n)
White 72.9(43)
Marital status, % (n)
With partner 89.8(53)
Without partner 10.2(6)
Schooling (years), Average (sd) 5.5(4)
Habits/ Lifestyle, % (n)
Currently a smoker 5.1(3)
Work status, % (n)
Inactive 76.3(45)
Active 15.2(9) 
Housewife 8.5(5)
Family income (MS) 3.6(3.2)
Table 1 – Socio-demographic and clinical characteristics 
of patients with CHD who were submitted to the 
strategies of planning for medication adherence (n=59). 
Campinas, São Paulo, Brazil, 2011-2012
Clinical Variables
Characterization of coronary disease, % (n)
Unstable Angina 25.4(15)
Myocardial infarction (MI) 74.6(44)
Number of previous MI, Average (sd) 1.0(1.3)
Number of Associated Clinical Conditions, Average (sd) 5.1(1.9)
Associated Clinical Conditions†, % (n)
Dyslipidemia 86.4(51)
Hypertension 84.7(50)
Diabetes mellitus 45.8(27)
Peripheral Artery Disease 22.0(13)
Heart failure 16.9(10)
Stroke 8.5(5)
Glucose intolerance 1.7(1)
Treatment, % (n)
Clinical and Intervention (MR/PTA/MR and PTA) 67.8(40)
Clinical 32.2(19) 
Number of medications in use, Average (sd) 6.8(2.0)
Number of Cardioprotective Medications - Average (sd) 3.5(0.6)
Number of symptom-relief medications, Average (sd) 0.9(0.7)
Morisky Score, Average (sd) 7.2(3.1)
Proportion of drug adherence, Average (sd) 92.1(13.7)
Proportion of adherence†, % (n)
Adequate dose (≥80%) 53(89.8)
Inadequate dose (<80%) 6(10.2)
Global evaluation of adherence†, % (n)
Adherents 19(32.2)
Non-adherents 40(67.8)
*sd = Standard deviation; †Percentage per line.
MS = minimum salary (1MS=R$ 545.00)
MR = Myocardial Revascularization
PTA = Percutaneous Transluminal Angioplasty
Description of Action and Coping Plans
The action plans most frequently devised in relation 
to when to take medication involved the associating 
of taking drugs with temporal markers such as meals 
(breakfast, lunch and dinner) and the sleep-wake cycle 
(on getting up and going to sleep). As for where to 
implement the behavior, plans associated with a specific 
place (at home or work) were most frequent, although 
plans for taking medication in any place were also found. 
Regarding how to take the medication, plans associated 
with meals were most noticeable (Table 2).
The barriers perceived to taking medications, and 
the plans for overcoming these barriers are presented in 
Tables 3, 4 and 5. It was determined to the participants 
to indicate barriers to taking medications in different 
situations; in daily life, during work activities and during 
leisure time. In daily life, the most frequently pointed-
out barriers were forgetfulness (46.9%), the absence 
of routine for associating taking medications with daily 
activities (26.0%) and unawareness about the disease (continue...)
Table 1 - (continuation)
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(7.3%). During work activities, barriers related to the 
need for a break at work were emphasized (33.3%), as 
for regular meals during work hours (25.0%), as well as 
for forgetfulness (12.5%). Forgetfulness was also highly 
frequently mentioned (73.3%) in leisure time. The 
formulation of a large number of plans for the issue of 
forgetting to take medications in daily life was observed, 
with the plan “Associating the taking of medications with 
temporal markers (meals) throughout the day” standing 
out (25.0%).
Table 2 – Description of Action Plans devised by the patients with CHD in relation to adherence to cardioprotective 
and symptom-relief drug therapy (n=59). Campinas, São Paulo, Brazil, 2011-2012
* Daily Living Activities
Table 3 – Coping Plans devised by the patients with CHD, relating to the behavior of adherence to cardioprotective 
and symptom-relief drug therapy in daily life (n=59). Campinas, São Paulo, Brazil, 2011-2012
In daily life
Perceived Obstacles/Barriers n % Coping plans n %
Forgetfulness
Forgetting to take the medications at 
the prescribed times
45 46.9 Associating the taking of medications with temporal markers (meals) 
throughout the day
24 25.0
Recording the times to take medications on the medications’ packaging 12 12.5
Request help from a family member to avoid forgetting the time to take the 
medications
9 9.4
Absence of family members for helping 
to remember taking the medications
8 8.3 Recording the times to take medications on the medications’ packaging 7 7.3
Memorizing the names of the medications and the times for taking them, in 
accordance with the prescription. 
1 1.0
Forgetting to buy and/or pick up the 
medication from the health services
7 7.3 Recording the date for buying or picking up the medications and fixing it to 
a highly visible place (e.g. the front of the refrigerator) 
5 5.2
Counting the total of medications on a weekly basis to ensure the pick up or 
purchase of the medications before they run out
2 2.1
Absence of routine
Absence of routine for the sleep-wake 
cycle
25 26.0 Establish a minimum routine for the sleep-wake cycle 23 23.9
Use strategies which help in the adoption of the routine for Sleep (use of an 
alarm clock, for example)
2 2.1
Not having habitual intervals for having 
meals throughout the day
16 16.7 Establish a routine for meals and associate the taking of medications with 
meals
16 16.7
Unawareness about the treatment
Unawareness about the action/purpose 
of the medications prescribed
7 7.3 Request guidance from doctor/health care professional in follow-up 
consultations
7 7.3
Total 96 100 Total 96 100
Action Plans n %
When (temporal markers)
Associating the taking of medications with the sleep-wake cycle and temporal markers – meals (breakfast, lunch and dinner) 24 40.7
Associating the taking of medications with going to bed and with temporal markers – meals (breakfast, lunch and dinner) 16 27.1
Associating the taking of medications with temporal markers – meals (breakfast, lunch and dinner) throughout the day 12 20.3
Associating the taking of medications with DLA* (e.g. after brushing teeth) and the temporal markers – meals (breakfast, 
lunch and dinner) 7 11.9
Where (in which place)
Only at home 37 62.7
Anywhere 14 23.7
At home and at work 8 13.5
How
Associating with meals and with a cup of water/juice 30 50.8
Fasting and associated with meals with a cup of water/juice 27 45.8
Unassociated with fasting and/or meals with a cup of water/-juice 2 3.9
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Table 4 – Coping Plans devised by the patients with CHD, related to the behavior of adherence to cardioprotective and 
symptom-relief drug therapy while at work (n=59). Campinas, São Paulo, Brazil, 2011-2012
At work
Perceived Obstacles/Barriers n % Coping Plans n %
Difficulty in taking medications at work
Difficulty in merging the time for taking medications with 
the break at work
8 33.3 Negotiate a break with the employer for taking 
medications in accordance with the prescription
8 33.3
Difficulty in unification of the taking of medications with 
the work 
7 29.2 Arrange a break in work activities for taking medications 7 29.2
Associating the taking of medications with meals and 
having difficulty in establishing a routine for meals in the 
workplace
6 25.0 Seek to establish a minimum routine for meals in the 
workplace
6 25
Forgetfulness
Forgetting to take medications at work 3 12.5 Place medications daily in a shirt/trouser pocket (men) or 
handbag (women) for taking to work 
3 12.5
Total 24 100 Total 24 100
Table 5 – Coping Plans devised by the patients with CHD, relating to the behavior of adherence to cardioprotective 
and symptom-relief drug therapy during leisure time (n=59). Campinas, São Paulo, Brazil, 2011-2012
Leisure time
Perceived Obstacles/Barriers n % Coping Plans n %
Forgetfulness
Forgetting to take the medications during habitual leisure 
activities
33 73.3 Separate the medications and take them in the pocket/
handbag
21 46.7
Separate the medications and take them in the pocket/
handbag along with a bottle of water
12 26.6
Forgetting to take the medications on outings/short trips 
away
9 20 Prioritize the placing of all the medications in the suitcase 9 20
Concomitant use with alcoholic drinks
Consuming alcoholic drinks concomitantly with the use of 
medications
3 6.7 Avoid consuming alcoholic drinks concomitantly with use 
of medications
3 6.7
Total 45 100 Total 45 100
Discussion
The present study’s aim was to describe the action 
plans and coping plans devised by outpatients with CHD 
under regular follow-up, relating to the behavior of 
adherence to cardioprotective and symptom-relief drug 
therapy indicated in the treatment of CHD.
Forming action and coping plans may be effective 
in implementing intention for different health-related 
behaviors. However, the use of this strategy entails 
that the people involved are capable of devising plans 
which lead to a behavioral change(7). There are reports 
that the plans’ quality influences the effectiveness of 
the adoption of the desired behavior(7,11). A previous 
study(19) showed that participants who were advised/
guided by the researcher in the production of plans for 
adhering to physical activity formulated more complete 
and thorough plans, compared to plans produced by 
the patients alone. In addition to this, an association 
was evidenced between plans that were more complete 
and higher levels of physical activity after six months’ 
monitoring.
Thus, in the present study, the low level of schooling 
associated with the recommendations of a previous 
study(6) contributed to the decision that the plans should 
be produced along with the researcher,  in a non-
directive manner, guided by the question: When, where 
and how do you plan to take the medications prescribed 
for the treatment of your heart problem, considering 
your day-to-day activities? Although some plans were 
devised independently, the majority was devised with 
the researcher, respecting the patients’ desires in the 
formulated plans. As a result of the joint planning, the 
plans were complete, encompassing when, where and 
how the action would be implemented. 
A randomized clinical trial tested the impact of the 
implementation of intention in clinically relevant changes 
in daily physical activity among adults in Holland. One 
of the reasons identified for the low effectiveness of the 
intervention was the fact that the plans were devised 
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autonomously by the participants, which may have 
influenced the plans` specificity and the quality(20).
Researchers(21) also hypothesize that specific 
plans are more likely to promote an intentional action 
compared to those produced in a generic way. This 
premise is based on the idea that through pondering 
a detailed description of the critical situation and the 
action to be carried out, the risk situation can easily 
be recognized and can trigger the action previously 
planned(7,11). A study(7) reported that instrumental plans 
(capable of promoting the change in behavior, and viable 
for the implementation of the intention in the context 
in which they were developed) with a high degree of 
specificity (those in which description of the situation 
is characterized by richness of details, facilitating 
recognition of the risk situation and the implementation 
of the action) resulted in a higher probability of 
abstinence from tobacco when compared to plans which 
were non-instrumental and of low specificity.
In the present study, the analysis of the plans 
evidenced that the largest number of plans was developed 
mentioning forgetfulness about taking medications in 
daily life. Additionally, it was observed that the plans 
related to forgetfulness in different situations (daily life, 
work and leisure time) were detailed and relevant to 
the context, with an exception for the plan “Memorizing 
the names of the medications and the times for taking 
them, in accordance with the prescription”, which was 
considered unlikely to lead to behavioral change in a 
population with a high average age and a low level of 
schooling. However, generic plans were also observed, 
mainly related to the absence of routine in daily life, 
as well as to the difficulty encountered in conciliating 
the taking of medications with work activities. It was 
observed that such plans can difficult the implementation 
of action in a risk situation. It may be hypothesized 
that the more frequent development of generic plans 
is related to the low level of schooling in the population 
studied.
On the other hand, there is a report(7) that over-
specifying actions does not necessarily result in beneficial 
effects, when one or more of the components of the 
desired action is not present or cannot be undertaken. 
Hence, the development of multiple and specific plans 
seems to be associated with a greater intervention effect. 
In the present study, however, it was not possible to 
analyze the number of plans devised, as the participants 
had been requested to devise up to three action plans, 
as recommended(6).
Studies on plans for medication adherence are 
scarce. One study(21) which tested the effectiveness 
of planning strategies in adherence to antibiotic drug 
therapy also found, among the barriers to adherence, 
forgetfulness and the need for changes in routines. 
Its findings suggested, however, that implementation 
intention is useful in the management of non-adherence 
from non-intentional causes such as forgetfulness, but 
is little effective in the promotion of complex behaviors, 
such as changes of routine.
Currently, huge efforts are being made to 
understand non-adherence to drug treatment, but this is 
a challenge yet to be met, as the mechanisms involved 
in the behavior of drug adherence are complex(22).
The future analysis of the results of the effectiveness 
of the implementation intention intervention among 
outpatients with CHD will contribute to refine this 
strategy with a view to replicating it in clinical practice.
Conclusion
The findings evidenced the elaboration of complete 
and specific action plans associating the taking of 
medications with temporal markers and the sleep-wake 
cycle. The development of specific coping plans for 
overcoming forgetfulness concerning taking medications 
and generic plans for supplying the lack of routine in 
daily activities related to the taking of medications 
was observed. These findings provide support for the 
application of the implementation intention technique in 
intervention studies intended to promote adherence to 
drug therapy among outpatients with CHD.
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